MobbleOpen in Mobble ⇢
Business · Stock markets · published 2026-10-11 · via Seeking Alpha

Celsius Moves Past Deals With Growth Prospects Intact

Image via Seeking Alpha
Image via Seeking Alpha

The article starts coverage of Celsius Holdings with a Buy rating, pointing to a 5.3% free cash flow yield and expected residual growth. It argues the recent decline in Celsius brand revenue reflects consolidation after acquisitions rather than a fundamental problem, as total portfolio retail sales in U.S. tracked channels rose 31% in Q2. International expansion is highlighted as a major opportunity, with management aiming for more than 15% of revenue from outside the U.S. by 2031.

Expanded Detail

Celsius Holdings has been launched with a Buy rating. The analyst cites a 5.3% free cash flow yield and a 9.6% weighted average cost of capital, implying about 4.3% residual yearly growth. The recent drop in Celsius-brand revenue is framed as consolidation following acquisitions, while total portfolio U.S. tracked retail sales climbed 31% in Q2.

International markets are seen as a key growth avenue. Management aims for non-U.S. sales to exceed 15% of revenue by 2031, following Monster Beverage’s global strategy. The energy drink category is expected to expand 8% annually through 2030, supporting Celsius’s runway even without market-share gains.

Context

Celsius’s expansion could influence investors watching cash returns and growth, while consumers may see more energy-drink choices and marketing. Employees and suppliers tied to the beverage sector could benefit if volumes rise, though competitive pressure may affect rivals. Broader societal effects may include shifts in retail shelf space and advertising, but the outcome depends on execution, category demand, and whether international sales meet targets.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Seeking Alpha →
Related stories
JPMorgan starts Savara at Overweight, betting on November FDA decision · Stock markets
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Acquisitions Digested, Celsius Is Positioned For Its Next Offense.” Browse more stories.